Prelude Therapeutics Incorporated (PRLD) News
Track canonical SquawkNews coverage tagged to PRLD, Prelude Therapeutics Incorporated. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Prelude Therapeutics clears FDA to start Phase 1 trial
The company received FDA clearance to proceed with a Phase 1 study of oral KAT6A degrader PRT13722. It expects patient enrollment in 4Q 2026.
EQUITY | Sep 10, 2026, 11:33 AM UTC
M
Prolight Diagnostics signs BRAINBox supply agreement worth $3.9 million
Prolight Diagnostics signed a supply agreement with BRAINBox valued at USD 3.9 million during the first year, according to an article published by BioStock.
EQUITY | Sep 08, 2026, 06:16 AM UTC
M
Prolight signs supply agreement with BRAINBox valued at USD 3.9M first year
Prolight Diagnostics AB (publ) said it signed a supply agreement with BRAINBox Solutions for instruments and cartridges. Anticipated first-year supply post FDA clearance and market launch is valued at USD 3.9 million.
REGULATION | Sep 07, 2026, 05:30 AM UTC
M
PRLD secures SEK 29M BRAINBox deal
PRLD secured a SEK 29M deal with BRAINBox, citing improved cash flow and narrower losses tied to strong TBI results.
EQUITY | Aug 27, 2026, 01:02 PM UTC
L
Prolight Diagnostics publishes half-year report for 2026
Prolight Diagnostics has published its half-year report for 2026.
EQUITY | Aug 27, 2026, 01:00 PM UTC
L
Prelude Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
Prelude Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
EARNINGS | Aug 11, 2026, 07:18 PM UTC
H
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Tuesday. Shares of Sherwin-Williams Co (NYSE: SHW ) rose sharply after the company reported better-than-expected second-quarter financial resu
EARNINGS | Jul 28, 2026, 02:05 PM UTC
L
PRLD +20% in pre-mkt INCY - Prelude Therapeutics shares are higher in pre-mkt after Incyte discontinues further development of INCB160058. [
PRLD +20% in pre-mkt INCY - Prelude Therapeutics shares are higher in pre-mkt after Incyte discontinues further development of INCB160058. [Prelude Therapeutics' corresponding drug candidate is PRT12396, a mutant-selecti
EQUITY | Jul 28, 2026, 12:53 PM UTC